Evaluation and management of end-stage liver disease in children

Mike A Leonis1, William F Balistreri

  • 1Pediatric Liver Care Center, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229, USA.

Gastroenterology
|May 13, 2008
PubMed

Insights

Pediatric end-stage liver disease (ESLD) requires specialized care, focusing on unique challenges like nutritional compromise and differing disease progression compared to adults. Effective management is crucial for survival and post-transplant outcomes in children with ESLD.

Area of Science:

  • Pediatric Gastroenterology and Hepatology
  • Internal Medicine
  • Transplantation Medicine

Background:

  • End-stage liver disease (ESLD) in children presents unique medical and psychosocial challenges.
  • Pediatric ESLD shares some complications with adult ESLD, such as ascites and variceal hemorrhage.
  • Disease progression and treatment responses in children can differ significantly from adults.

Purpose of the Study:

  • To review key aspects of evaluating and managing pediatric end-stage liver disease.
  • To highlight the specific vulnerabilities and considerations in pediatric ESLD care.
  • To optimize health care delivery for children with chronic liver disease.

Main Methods:

  • This is a review article.
  • It synthesizes current knowledge on pediatric end-stage liver disease.
  • Focuses on evaluation and management strategies.

Main Results:

  • Children with ESLD are particularly susceptible to nutritional compromise, impacting outcomes.
  • Vaccination status and care setting are critical for optimizing pediatric health outcomes.
  • Effective management strategies are essential for survival and post-transplant success.

Conclusions:

  • Pediatric end-stage liver disease necessitates a tailored approach considering nutritional support, vaccination, and care environment.
  • Early and effective management is vital for improving long-term survival and outcomes in pediatric liver disease patients.
  • This review provides a framework for comprehensive care in pediatric ESLD.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...